End-Stage Renal Disease (ESRD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034
End-Stage Renal Disease (ESRD) Market Outlook Thelansis’s “End-Stage Renal Disease (ESRD) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential End-Stage Renal Disease (ESRD) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). End-Stage Renal Disease (ESRD) Overview End-stage renal disease (ESRD) represents the irreversible phase of kidney dysfunction that cannot be effectively managed through conservative measures alone, necessitating either dialysis or kidney transplantation for survival. There are two primary forms of kidney impairment leading to ESRD: acute and chronic. Chronic renal failure (CRF), which signifies ESRD, deno...